104 related articles for article (PubMed ID: 1225382)
1. A study on the clinical significance of urinary beta-aminoisobutyric acid in patients with urothelial tumours.
Nyholm KK; Sjölin KE; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1975 Nov; 22(6):509-16. PubMed ID: 1225382
[TBL] [Abstract][Full Text] [Related]
2. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
[TBL] [Abstract][Full Text] [Related]
3. Beta-aminoisobutyric acid in urine from patients with urothelial tumours.
Nielsen HR; Nyholm K; Sjölin KE
Rev Eur Etud Clin Biol; 1971 May; 16(5):444-50. PubMed ID: 5113307
[No Abstract] [Full Text] [Related]
4. Correlations of beta-aminoisobutyric acid in 8 hour and 24 hour urinary samples determined by dual column gas chromatography.
Sjölin KE; Nyholm KK
Biomedicine; 1980 May; 32(2):60-5. PubMed ID: 7388117
[TBL] [Abstract][Full Text] [Related]
5. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Kvist E; Sjølin KE; Iversen J
Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder.
Kvist E; Sjølin KE; Iversen J; Nyholm K
Scand J Urol Nephrol; 1993; 27(1):45-53. PubMed ID: 8493467
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of beta-aminoisobutyric acid in hematological diseases.
Enkhjargal Ts; Tserennadmid Ch
Rinsho Byori; 2004 Jan; 52(1):17-21. PubMed ID: 14968554
[TBL] [Abstract][Full Text] [Related]
8. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
[TBL] [Abstract][Full Text] [Related]
9. [Recurring urothelial tumours of the urinary tract (author's transl)].
Flamm J
Wien Med Wochenschr; 1979 Oct; 129(19):535-40. PubMed ID: 516751
[TBL] [Abstract][Full Text] [Related]
10. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
[TBL] [Abstract][Full Text] [Related]
11. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
14. Biochemically detectable tumor markers in urine of bladder cancer patients.
Irving CC
Cancer Res; 1977 Aug; 37(8 Pt 2):2872-4. PubMed ID: 872116
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent urothelial cancer after resection of ureteral carcinoma].
Kong C; Ci J; Liu T
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary excretion of beta-aminoisobutyric acid in a Danish family.
Sjølin KE
Dan Med Bull; 1988 Aug; 35(4):397-9. PubMed ID: 3168560
[TBL] [Abstract][Full Text] [Related]
17. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
18. [Tumors of the upper urinary tract: results of conservative surgery].
Djokic M; Hadzi-Djokic J; Nikolic J; Dragicevic D; Durutovic O; Radivojevic D
Prog Urol; 2001 Dec; 11(6):1231-8. PubMed ID: 11859657
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of beta-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia.
Nielsen HR; Killmann SA
J Natl Cancer Inst; 1983 Nov; 71(5):887-91. PubMed ID: 6580488
[TBL] [Abstract][Full Text] [Related]
20. Cytokine levels in patients with urinary tract cancer.
Stefanovic V; Bogicevic M; Stamenic T; Ignjatovic I; Vlahovic P; Mitic M
Pathol Biol (Paris); 1994 Nov; 42(9):842-6. PubMed ID: 7753593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
